PLA2R自身抗体在膜性肾病诊断前的检测
该研究利用美国国防部血清库,对134例原发性膜性肾病、35例继发性膜性肾病和134名健康志愿者的1054份纵向血清样本进行PLA2R抗体分析。结果显示44%的原发性膜性肾病患者在肾活检诊断前中位274天即可检测到PLA2R抗体,且部分早于非肾病范围蛋白尿和低白蛋白血症出现。
要点
- 原发性膜性肾病患者中44%在诊断前可检出PLA2R抗体,中位提前274天。
- PLA2R抗体可早于非肾病范围蛋白尿和低白蛋白血症出现。
- 继发性膜性肾病和健康对照中PLA2R抗体阳性率极低。
核心结论
- 循环PLA2R抗体可在膜性肾病临床诊断前数月至数年检测到。
研究设计与样本
- 利用美国国防部血清库,分析134例原发性膜性肾病、35例继发性膜性肾病和134名健康志愿者的1054份纵向血清样本。
主要发现
- 原发性膜性肾病患者PLA2R抗体阳性率为44%(59/134),继发性膜性肾病为3%(1/35),健康对照为0%。
- PLA2R抗体在肾活检诊断前中位274天(四分位距71-821天)可检测到。
- 约三分之一参与者在膜性肾病诊断后3个月内出现血清阳性。
- 21例有诊断前非肾病范围蛋白尿记录者中,43%(9/21)在蛋白尿出现前抗体阳性,28.5%(6/21)同时阳性。
临床怎么用
- 对于疑似原发性膜性肾病患者,PLA2R抗体检测有助于早期识别和监测疾病进程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating serum autoantibodies against the M-type phospholipase A2 receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary membranous nephropathy (MN). However, little is known about the appearance and trajectory of PLA2R-AB before the clinical diagnosis of MN. METHODS: Using the Department of Defense Serum Repository, we analyzed PLA2R-AB in multiple, 1054 longitudinal serum samples collected before diagnosis of MN from 134 individuals with primary MN, 35 individuals with secondary MN, and 134 healthy volunteers. We evaluated the presence and timing of non-nephrotic range proteinuria (NNRP) and serum albumin measurements in relation to PLA2R-AB status. RESULTS: Analysis of PLA2R-AB in longitudinal serum samples revealed seropositivity in 44% (59 out of 134) of primary MN cases, 3% (one out of 35) of secondary MN cases, and in 0% of healthy controls. Among patients with MN, PLA2R-AB were detectable at a median of 274 days before renal biopsy diagnosis (interquartile range, 71-821 days). Approximately one third of the participants became seropositive within 3 months of MN diagnosis. Of the 21 individuals with documented prediagnostic NNRP, 43% (nine out of 21) were seropositive before NNRP was first documented and 28.5% (six out of 21) were seropositive at the same time as NNRP; 66% (39 out of 59) of those seropositive for PLA2R-AB had hypoalbuminemia present at the time antibody was initially detected. Twelve participants (20%) were seropositive before hypoalbuminemia became apparent, and eight participants (14%) were seropositive after hypoalbuminemia became apparent. CONCLUSIONS: Circulating PLA2R-AB are detectable months to years before documented NNRP and biopsy-proven diagnosis in patients with MN.
引用
- Burbelo PD, Joshi M, Chaturvedi A, et al. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy. J Am Soc Nephrol. 2019. PMID: 31843984. doi:10.1681/ASN.2019050538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。